Phase III Study of Chemotherapy in Combination With ATRA With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia and NPM1 Gene Mutation.
Phase of Trial: Phase III
Latest Information Update: 18 May 2017
At a glance
- Drugs Gemtuzumab ozogamicin (Primary) ; Cytarabine; Etoposide; Idarubicin; Pegfilgrastim; Tretinoin
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 24 Jan 2014 As per the ClinicalTrials.gov record, planned End Date changed from 1 Feb 2016 to 1 Jan 2020.
- 10 Jul 2012 Planned End Date changed from 1 Feb 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.
- 06 Jun 2012 New source identified and integrated (German Clinical Trials Register: DRKS00003759).